Using Saline for Myofascial Pain Syndromes (USAMPS)

Stopped early · Phase 4

Conditions studied: Myofascial Pain Syndrome

In brief

This study involves adult patients diagnosed with Myofascial Pain Syndromes (MPS). The purpose of this research study is to determine if there is a therapeutic difference between trigger point injection (TPI) of normal saline and conventional drug mix (local anesthesic + steroid) in treating MPS.

Key facts

Study ID

NCT02120261

Run by

The University of Texas Health Science Center, Houston

People needed

51

Starts

2014-05-01

Expected to finish

2016-11-01

Last updated by the study team

2019-05-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients diagnosed with MPS of the trapezius, gluteus medius/minimus, iliocostalis thoracis-lumborum, quadratus Lumborum, or paraspinal muscles in the emergency department.

You may not qualify if…

• Patients allergic to lidocaine and/or steroids.
• Pregnant women.
• Prisoners.
• Patients who are cognitively impaired and/or unable to consent for the study.
• Age < 18.
• Signs of localized infection or skin breakdown at the injection site.

Where it is running

• Lyndon Baines Johnson General Hospital — Houston, Texas, United States
• Memorial Hermann Hospital Texas Medical Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.